Results
1 -
10 of
11
(Click
here to explore results)
- Drug Discovery for Schizophrenia, CHAPTER 5 Modelling Schizophrenia: Strategies for Identifying Improved Platforms for Drug Discovery. John L. Waddington, Colm M. P. O’Tuathaigh
, 2015
, Pages 89-114
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 9 Heterocycles Containing Nitrogen and Sulfur as Potent Biologically Active Scaffolds. Ana Martinez, Carmen Gil
, 2016
, Pages 231-261
- Drug Discovery for Schizophrenia, CHAPTER 8 GSK3 Networks in Schizophrenia. Jivan Khlghatyan, Gohar Fakhfouri, Jean-Martin Beaulieu
, 2015
, Pages 173-201
- Emerging Drugs and Targets for Multiple Sclerosis, CHAPTER 8 Protein Kinase Inhibitors for the Treatment of Multiple Sclerosis. Ana Martinez, Carmen Gil
, 2019
, Pages 170-196
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- Gasotransmitters, Chapter 5 Production and Signaling Functions of Ammonia in Mammalian Cells. Ziqiang Meng, Rui Wang
, 2018
, Pages 101-144
- Orphan Drugs and Rare Diseases, Chapter 11 Drug Discovery Approaches for Rare Neuromuscular Diseases. Graham M. Wynne, Angela J. Russell
, 2014
, Pages 257-343
- Neglected Diseases and Drug Discovery, Chapter 3 Antimalarial Agents Targeting Nucleotide Synthesis and Electron Transport: Insight from Structural Biology. Margaret A. Phillips
, 2012
, Pages 65-87
- Animal Models for Neurodegenerative Disease, Chapter 13 A Non-transgenic Rat Model of Sporadic Alzheimer's Disease. Khalid Iqbal, Xiaochuan Wang, Julie Blanchard, Inge Grundke-Iqbal
, 2011
, Pages 274-283
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 11 LRRK2 Kinase Inhibitors as New Drugs for Parkinson’s Disease?. Sandra Schulz, Stefan Göring, Boris Schmidt, Carsten Hopf
, 2013
, Pages 266-293